Literature DB >> 12504629

Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomy.

Christina S Chu1, Thomas C Randall, Christina A Bandera, Stephen C Rubin.   

Abstract

BACKGROUND: Laparoscopic-assisted vaginal hysterectomy (LAVH) has been suggested as an alternative to total abdominal hysterectomy (TAH) for the treatment of early endometrial cancer. Although studies have reported good results with equivalent rates of recurrence and survival, the need for use of intrauterine manipulators during the LAVH raises the concern for operative dissemination of tumor cells. CASES: We report three patients with stage I, noninvasive or superficially invasive endometrial cancer with vaginal cuff recurrence within 9 months of treatment by LAVH.
CONCLUSION: While LAVH may be a technically acceptable alternative to TAH for the management of early-stage endometrial cancer, its routine use should be undertaken with caution, as the long-term risks for recurrence and survival have yet to be defined in a randomized, controlled fashion.

Entities:  

Mesh:

Year:  2003        PMID: 12504629     DOI: 10.1006/gyno.2002.6852

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Laparoscopy or laparotomy? A comparison of 240 patients with early-stage endometrial cancer.

Authors:  Alessandro Santi; Annette Kuhn; Thomas Gyr; Markus Eberhard; Silke Johann; Andreas R Günthert; Michael D Mueller
Journal:  Surg Endosc       Date:  2009-06-16       Impact factor: 4.584

2.  Identifying the superior surgical procedure for endometrial cancer: A protocol of network meta-analysis.

Authors:  Min Yin; Yitong Cai; Li Zhou
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  Laparoscopic-assisted staging surgery for Korean women with endometrial cancer.

Authors:  Jung Hun Lee; Un Suk Jung; Min Sun Kyung; Joong Sub Choi
Journal:  JSLS       Date:  2008 Apr-Jun       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.